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Vitamin D plays an important role in Ca2 homeostasis by controlling Ca2 (re)absorption in intestine, kidney, and bone. The
epithelial Ca2 channel TRPV5 mediates the Ca2 entry step in active Ca2 reabsorption. TRPV5 knockout (TRPV5/) mice
show impaired Ca2 reabsorption, hypercalciuria, hypervitaminosis D, and intestinal hyperabsorption of Ca2. Moreover,
these mice demonstrate upregulation of intestinal TRPV6 and calbindin-D9K expression compared with wild-type mice. For
addressing the role of the observed hypervitaminosis D in the maintenance of Ca2 homeostasis and the regulation of
expression levels of the Ca2 transport proteins in kidney and intestine, TRPV5/25-hydroxyvitamin-D3-1-hydroxylase double
knockout (TRPV5//1-OHase/) mice, which show undetectable serum 1,25(OH)2D3 levels, were generated. TRPV5
//
1-OHase/ mice displayed a significant hypocalcemia compared with wild-type mice (1.10  0.02 and 2.54  0.01 mM,
respectively; P < 0.05). mRNA levels of renal calbindin-D28K (7  2%), calbindin-D9K (32  4%), Na
/Ca2 exchanger (12 
2%), and intestinal TRPV6 (40  8%) and calbindin-D9K (26  4%) expression levels were decreased compared with wild-type
mice. Hyperparathyroidism and rickets were present in TRPV5//1-OHase/ mice, more pronounced than observed in
single TRPV5 or 1-OHase knockout mice. It is interesting that a renal Ca2 leak, as demonstrated in TRPV5/ mice,
persisted in TRPV5//1-OHase/mice, but a compensatory upregulation of intestinal Ca2 transporters was abolished. In
conclusion, the elevation of serum 1,25(OH)2D3 levels in TRPV5
/mice is responsible for the upregulation of intestinal Ca2
transporters and Ca2 hyperabsorption. Hypervitaminosis D, therefore, is of crucial importance to maintain normocalcemia in
impaired Ca2 reabsorption in TRPV5/ mice.
J Am Soc Nephrol 16: 3188–3195, 2005. doi: 10.1681/ASN.2005060632
C a
2 is one of the most important cations in the human
body as it is essential for many physiologic functions,
including neuronal excitation, cardiac muscle contrac-
tion, blood clotting, and bone mineralization. Therefore, Ca2
balance is tightly controlled by the concerted action of intestinal
Ca2 absorption, exchange of Ca2 from bone, and Ca2 reab-
sorption in the kidney (1). The active form of vitamin D, 1,25-
dihydroxyvitamin D3 (1,25(OH)2D3), and parathyroid hormone
(PTH) and calcitonin are the calciotropic hormones that are
known to be involved in the maintenance of plasma Ca2 concen-
tration (2,3). Ca2 absorption from the intestinal lumen and Ca2
reabsorption in the renal tubules is promoted by 1,25(OH)2D3
(4–6). Synthesis of 1,25(OH)2D3 requires the renal cytochrome
P450 enzyme 25-hydroxyvitamin D3-1-hydroxylase (1-OHase)
(7). In addition, PTH stimulates 1,25(OH)2D3 production by 1-
OHase activation and the release of Ca2 from bone to maintain
plasma Ca2 levels, whereas calcitonin lowers the plasma Ca2
concentration by inhibition of bone resorption (2).
1,25(OH)2D3-stimulated transepithelial Ca
2 transport in
kidney and intestine involves Ca2 entry across the apical
membrane via the epithelial Ca2 channels TRPV5 and TRPV6,
respectively. TRPV5 is localized at the luminal membrane of the
late distal convoluted tubule (DCT) and connecting tubule
(CNT) in kidney (8,9). TRPV6 is the homologues Ca2 channel
localized in the brush border membrane of duodenum (1,10–
13). After entry of Ca2 through TRPV5 and TRPV6, Ca2
bound to Ca2-binding proteins (calbindins) diffuses to the
basolateral membrane of the cell. Ca2 is finally extruded to the
extracellular compartment by the Na/Ca2 exchanger
(NCX1) in the kidney and the plasma membrane Ca2-ATPase
(PMCA1b) in intestine and kidney (9).
Recently, several animal models were designed to investigate
Ca2 absorption mechanisms and maintenance of Ca2 bal-
ance. TRPV5 knockout (TRPV5/) mice were generated by
targeted ablation of the TRPV5 gene. These mice displayed
robust renal Ca2 wasting as a result of impaired Ca2 reab-
sorption in DCT and CNT (14). Furthermore, elevated
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1,25(OH)2D3 serum levels, intestinal Ca
2 hyperabsorption, and
reduced bone thickness andmineralizationwere demonstrated. In
addition, Dardenne et al. (15) created an animal model for vitamin
D deficiency rickets type 1 by genetic ablation of the 1-OHase
gene. These 1-OHase knockout (1-OHase/) mice showed a
phenotype characterized by undetectable serum levels of
1,25(OH)2D3, severe hypocalcemia, hyperparathyroidism, bone
abnormalities, and retarded growth (15–17). Until now, data on
detailed urine analysis of the 1-OHase/ mice were not avail-
able. Previous studies demonstrated that 1,25(OH)2D3 supple-
mentation rescues the severe phenotype of 1-OHase/ mice,
which is accompanied by an upregulation of TRPV5, TRPV6,
calbindins, NCX1, and PMCA1b expression, resulting in the nor-
malization of serum Ca2 levels. It is interesting that dietary Ca2
supplementation in 1-OHase/ mice resulted in a similar res-
cue in the absence of 1,25(OH)2D3. Taken together, these studies
suggest a pivotal role of the Ca2 transport proteins in maintain-
ing Ca2 balance, partly independent of 1,25(OH2)D3 (18).
To investigate the contribution of elevated 1,25(OH)2D3 lev-
els to the phenotype of TRPV5/ mice and to elucidate the
involvement of 1,25(OH)2D3 in the compensatory Ca
2 hypera-
bsorption, we generated a mouse model in which both TRPV5
and 1-OHase were inactivated. In this study, we describe the
phenotype of TRPV5/1-OHase double knockout (TRPV5//
1-OHase/) mice, including bone analysis and semiquanti-
fication of mRNA and protein expression levels of Ca2 trans-
port proteins and provide an extensive comparison with
TRPV5 and 1-OHase single knockout mice.
Materials and Methods
Animal Experiments
TRPV5/ mice were generated as described previously (14). 1-
OHase/ mice were provided by Rene´ St-Arnaud (Shriners Hospital
for Children Montreal, QU, Canada) (15). Cross-breeding of 1-
OHase/ and TRPV5/ mice resulted in offspring that were het-
erozygous for both TRPV5 and 1-OHase (TRPV5//1-OHase/).
This offspring was subsequently intercrossed to obtain TRPV5//1-
OHase/ mice. Genotypes were determined by PCR analysis, using
specific primers as described previously (14,15). For obtaining 24-h
urine samples of all mouse genotypes, 8-wk-old mice were kept in a
light- and temperature-controlled room in metabolic cages that enabled
24-h urine analyses. Standard pelleted chow (0.25% [wt/vol] Na, 1.1%
[wt/vol] Ca, 0.2% [wt/vol] Mg, 0.7% [wt/vol] P, and 0.9% [wt/vol] K)
and drinking water were available ad libitum. After the experiment,
blood was collected and mice were killed. Kidney, duodenum, tibia,
and fibula were sampled. The animal ethics board of the Radboud
University Nijmegen approved all animal experimental procedures.
Urine and Serum Analyses
Urine and serum Ca2 concentrations were analyzed using a color-
imetric assay kit (Roche, Mannheim, Germany). An electronic ion an-
alyzer was used to determine urinary pH. Serum vitamin D levels were
determined with a [125I]1,25(OH)2D3 RIA assay (IDS Inc., Fountain
Hills, AZ). Mouse serum PTH was measured using an immunoradio-
metric assay (Immutopics Inc., San Clemente, CA).
Real-Time Quantitative PCR Analysis
For investigating mRNA expression levels of renal and duodenal
Ca2 transport proteins, total RNA from kidney and duodenum was
isolated using TriZol Reagent (Life Technologies BRL, Life Technolo-
gies, Breda, The Netherlands) according to the manufacturer’s protocol.
RNA was treated with DNase (Promega, Madison, WI) to prevent
contamination with genomic DNA. Total RNA was subjected to reverse
transcription using Moloney-murine leukemia virus–reverse transcrip-
tase (Life Technologies BRL, Life Technologies, Breda, The Nether-
lands) (11). Renal mRNA expression levels of calbindin-D28K; calbin-
din-D9K; NCX1; and duodenal TRPV6, calbindin-D9K, and PMCA1b
mRNA levels were quantified by real-time quantitative PCR as de-
scribed previously (19,20), using the ABI Prism 7700 Sequence Detec-
tion System (PE Biosystems, Rotkreuz, Switzerland). The expression
level of the housekeeping gene hypoxanthine-guanine phosphoribosyl
transferase was used as an endogenous control.
Immunoblotting
Total kidney lysates of TRPV5/ and TRPV5//1-OHase/
mice were prepared as described previously (21). The protein concen-
tration of the homogenates was determined with the Bio-Rad protein
assay (Bio-Rad, Mu¨nchen, Germany). Samples were submitted to 16.5%
(wt/vol) SDS-PAGE and blotted to polyvinyldifluoride-nitrocellulose
Figure 1.Urinary Ca2 excretion and serum Ca2 concentration.
Urinary Ca2 excretion (A) and serum Ca2 levels (B) were
determined in wild-type, 1-OHase/, TRPV5/, and
TRPV5/1-OHase/ mice. Data are presented as means 
SEM. *P  0.05, significant difference from all groups.
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membranes (Immobilon-P, Millipore Corp., Bedford, MA). Blots were
incubated with a rabbit anti–calbindin-D28K polyclonal antibody (1:
10,000) (22) or a rabbit anti–calbindin-D9K polyclonal antibody (1:5000;
Swant, Bellinzona, Switzerland) at 4°C for 16 h. Subsequently, blots
were incubated with a goat anti-rabbit peroxidase-labeled secondary
antibody (1:10,000; Sigma, St. Louis, MO). Immunoreactive protein was
detected by the chemiluminescence method (Pierce, Rockford, IL). Im-
munopositive bands were scanned using an imaging densitometer
(Bio-Rad Gs-690) to determine pixel density (Molecular Analyst Soft-
ware; BioRad Laboratories, Hercules, CA).
Bone Analyses
For evaluating the effects of TRPV5 and 1-OHase-ablation on bone
homeostasis, bone thickness, mineralization, and epiphyseal growth
plate development were determined in tibiae from wild-type,
TRPV5/, 1-OHase/, and TRPV5//1-OHase/ mice using
microcomputed tomography (Skyscan 1072; SkyScan, Antwerp, Bel-
gium). This technique allows for high-resolution, noninvasive com-
puted tomographic imaging in small animals and small animal organs.
Tibiae and fibulae were fixed in 4% (vol/vol) PBS-buffered formalde-
hyde and routinely processed for plastic embedding (23). The bones
were scanned using the SkyScan 1072 microtomograph, and digital
cross-sections were made at the site of the diaphysis and epiphysis.
X-ray imaging of tibiae and fibulae was performed to compare bone
lengths and mineralization in all mouse genotypes.
Statistical Analyses
Values are expressed as means  SEM. Statistical significance (P 
0.05) was determined by one-way ANOVA. All analyses were per-
formed using the Statview Statistical Package software (Power PC
version 4.51, Berkeley, CA) on an Apple iMac computer.
Results
Animal Experiments
TRPV5/ mice showed hypercalciuria along with normal
serum Ca2 levels, a significant increase of serum 1,25(OH)2D3
levels, and normal serum PTH levels. Moreover, TRPV5/
mice displayed an increased diuresis and a decrease of urine
pH (Figure 1 and Table 1). 1-OHase/ mice displayed hy-
pocalciuria, hypocalcemia, serum 1,25(OH)2D3 levels below the
detection level (6 pmol/L), and a significant hyperparathy-
roidism. In comparison with wild-type mice, diuresis and urine
pH were normal in 1-OHase/ mice. The analysis of the
TRPV5//1-OHase/ mice phenotype showed that net
urine Ca2 excretion does not differ from wild-type mice, al-
though inappropriately high given the severe hypocalcemia.
Serum 1,25(OH)2D3 levels were below detectable levels, and
serum PTH levels were further elevated in TRPV5//1-
OHase/ mice compared with 1-OHase/ mice. In addi-
tion, diuresis and urine pH were normalized in TRPV5//1-
OHase/ mice. Body weight was reduced in 1-OHase/
and TRPV5//1-OHase/ mice compared with litter-
matched wild-type mice. 1-OHase/ and TRPV5//1-
OHase/ mice had a decreased lifespan in comparison with
wild-type and TRPV5/ mice.
Renal mRNA and Protein Expression of Ca2 Transporters
To investigate the specific regulation of renal Ca2 transport-
ers by 1,25(OH)2D3, we determined the effects of TRPV5 and
1-OHase single or combined gene ablation on mRNA and
protein expression levels by real-time PCR analysis and semi-
quantitative immunoblotting. Calbindin-D28K, calbindin-D9K,
and NCX1 mRNA expression levels were decreased in kidneys
of TRPV5/ and 1-OHase/ mice compared with wild-
type mice (Figure 2). It is interesting that a further significant
decrease in the expression of these Ca2 transporters was de-
tected in TRPV5//1-OHase/ mice. Calbindin-D28K and
calbindin-D9K protein abundance was significantly decreased
in TRPV5//1-OHase/ mice compared with TRPV5/
mice as detected by immunoblot (Figure 3).
Duodenal mRNA Expression of Ca2 Transporters
To evaluate the contribution of 1,25(OH)2D3 to expression of
the duodenal Ca2 transporters, we determined mRNA levels
of TRPV6, calbindin-D9K, and PMCA1b. TRPV5
/ mice
showed a significant increase in duodenal TRPV6 and calbi-
ndin-D9K mRNA levels compared with wild-type mice (Figure
4). Additional 1-OHase ablation resulted in a significant de-
crease in TRPV6 and calbindin-D9K expression in duodenum.
Furthermore, 1-OHase/ mice demonstrated a downregula-
tion of TRPV6 and calbindin-D9K mRNA expression. PMCA1b
expression levels did not differ significantly between the stud-
ied mouse genotypes.
Table 1. Urine and serum analyses and body weighta
Wild-Type 1-OHase/ TRPV5/ TRPV5//1-OHase/
Urine
Diuresis (ml/24 h) 1.8 0.2 2.3  0.3 4.4  0.6b 1.8 0.5
pH 7.6 0.2 7.9 0.1 6.1  0.1b 7.8 0.2
Serum
1,25(OH)2D3 (pmol/L) 193 27 6 632 63
b 6
PTH (pg/ml) 44 10 1444 123b 29 6 2328  212b
Body weight (g) 24.6 1.7 14.1  0.4b 21.7 0.8 12.8 1.1b
aData are presented as means  SEM. 1-OHase/, 1-OHase knockout mice; TRPV5/, TRPV5 knockout mice;
TRPV5//1-OHase/, TRPV5/1-OHase double knockout mice; PTH, parathyroid hormone. The minimum detection
level of the 1,25(OH)2D3 assay was 6 pmol/L.
bP  0.05, significant difference from wild-type mice.
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Bone Analyses
Bone analyses showed that TRPV5/ mice (Figure 5, J and
N) and 1-OHase/ mice (Figure 5, K and O) demonstrated
reduced bone thickness in both the trabecular and the cortical
compartments compared with wild-type mice (Figure 5, I and
M). This reduction was more severe in 1-OHase/ mice
(Figure 5, K and O). In addition, the degree of bone mineral-
ization was reduced in TRPV5/ mice (Figure 5, F, J, and N)
and 1-OHase/ mice (Figure 5, G, K, and O) compared with
wild-type mice (Figure 5, E, I, and M). Moreover, the epiphy-
seal growth plate was widened in 1-OHase/mice (Figure 5,
G versus E), which was not observed in TRPV5/mice (Figure
5, F versus E). Tibial bone length was reduced in 1-OHase/
mice (Figure 5, C versus A and B). In TRPV5//
1-OHase/ mice, the thickness of cortical bone and trabec-
ulae was decreased and mineralization was diminished com-
pared with all other mouse genotypes (Figure 5, H, L, and P).
Moreover, tibial bone length was severely reduced and epiph-
yseal growth plate widening was more pronounced in
TRPV5//1-OHase/ mice than demonstrated in 1-
OHase/ mice (Figure 5, D and H versus C and G). Taken
together, the TRPV5//1-OHase/ mice exhibited an ag-
gravated skeletal phenotype in comparison with TRPV5/
and 1-OHase/ mice (Figure 5, D, H, L, and P).
Discussion
This study demonstrated that hypervitaminosis D in
TRPV5/mice is responsible for the upregulation of intestinal
Ca2 transport proteins and the resulting Ca2 hyperabsorp-
tion. Hereby, TRPV5/ mice maintain normocalcemia, a fea-
ture absent in TRPV5//1-OHase/ mice, which exhibit a
significant hypocalcemia. The urinary Ca2 leak demonstrated
in TRPV5/ mice persists in the TRPV5//1-OHase/
mice as an inappropriately high urinary Ca2 excretion with
respect to the hypocalcemia. Moreover, bone degradation is
present in TRPV5//1-OHase/ mice, more severe than
observed in TRPV5/ mice. Therefore, the absence of Ca2
hyperabsorption results in a more aggravated phenotype than
described for TRPV5 single-ablated mice. Thus, 1,25(OH)2D3 is
of crucial importance to compensate the renal Ca2 leak and to
maintain normal serum Ca2 levels in TRPV5/ mice.
1,25(OH)2D3 is an important regulatory hormone in Ca
2
and bone homeostasis (2). In duodenum, 1,25(OH)2D3 regulates
the expression of Ca2 transport proteins (24). Moreover,
1,25(OH)2D3 is synthesized from its precursor by the renal
enzyme 1-OHase (7). 1-OHase/ mice were previously
generated as a mouse model for vitamin D deficiency rickets
type I (15,16). Inactivation of 1-OHase resulted in undetectable
levels of serum 1,25(OH)2D3, a significant hypocalcemia, and
reduced expression levels of duodenal Ca2 transport proteins.
In contrast, TRPV5/ mice demonstrated a normocalcemia
with a significant hypervitaminosis D and increased duodenal
Ca2 transport protein expression leading to Ca2 hyperab-
sorption (14). We hypothesized that the increased serum
1,25(OH)2D3 levels constitute a compensatory mechanism in an
effort to correct for the significant renal Ca2 leak. Additional
gene inactivation of 1-OHase in TRPV5/ mice was per-
Figure 2. Renal mRNA expression of Ca2 transport proteins.
Renal mRNA expression levels of calbindin-D28K (A), calbin-
din-D9K (B), and NCX1 (C) in wild-type, 1-OHase
/,
TRPV5/, and TRPV5/1-OHase/ mice, assessed by re-
al-time PCR analysis as the ratio to hypoxanthine-guanine
phosphoribosyl transferase (HPRT) mRNA levels. Expression
levels are presented relative to wild-type mice. Data are ex-
pressed as means  SEM. *P  0.05 significant difference from
wild-type mice; #P 0.05 significant difference from all groups.
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formed to investigate the effects of the elevated serum
1,25(OH)2D3 levels present in TRPV5
/ mice. This double
gene ablation resulted in undetectable serum 1,25(OH)2D3 lev-
els and downregulation of duodenal Ca2 transport protein
expression. Moreover, a hypocalcemia developed in the
TRPV5//1-OHase/ mice. These data clearly showed
that the increased expression of the intestinal Ca2 transporters
TRPV6 and calbindin-D9K and the resulting Ca
2 hyperabsorp-
tion in TRPV5/ mice are due to a secondary hypervitamin-
osis D. These effects compensate for the renal Ca2 leak to
maintain normal serum Ca2 levels in TRPV5/ mice.
TRPV5/ mice show a striking hypercalciuria. Previous
micropuncture experiments demonstrated that Ca2 reabsorp-
tion in DCT and CNT is abolished in these mice, illustrating a
primary defect in renal active Ca2 reabsorption (14). On the
contrary, 1-OHase/ mice demonstrated a significant hy-
pocalciuria, a feature not described before, although explained
by the downregulation of intestinal and renal Ca2 transport
proteins and, therefore, impairment of Ca2 absorption and
reabsorption. It is interesting that additional gene ablation of
1-OHase in TRPV5/ mice normalized 24-h urinary Ca2
excretion to values not significantly different from wild-type
mice. Nevertheless, relative to the severe hypocalcemia, these
double knockout mice still excreted inappropriately high
amounts of Ca2. Moreover, given the expression of the renal
Ca2 transporters in 1-OHase/ mice, it can be concluded
that active Ca2 reabsorption is still present, although severely
impaired despite the absence of 1,25(OH)2D3. Ca
2 reabsorp-
tion through TRPV5 therefore could be partly independent on
1,25(OH)2D3, which is in line with the results of previous
studies in which the rescue of 1-OHase/ mice by dietary
Ca2 was described, showing the regulation of Ca2 transport
proteins independent of 1,25(OH)2D3 regulation (18,25).
Hypercalciuria increases the risk for the formation of Ca2-
containing urinary crystals (26,27). In addition to hypercalci-
uria, TRPV5/ mice displayed a significant polyuria and
urine acidification. Polyuria facilitates the excretion of large
quantities of Ca2, and urine acidification creates an environ-
ment in which formation of crystals is restrained (28,29). It is
interesting that in the double knockout mice, net calciuresis did
not differ from wild-type mice and neither did urinary pH or
diuresis. This indicated that the hypercalciuria in TRPV5/
mice, which originates from the DCT and CNT, could indeed
influence diuresis and pH in more distal located nephron seg-
ments. Previously, thiazide treatment leading to a decrease in
Ca2 excretion in TRPV5/ mice was shown to normalize
urinary pH and blunt polyuria (30). It was postulated that
calcium-sensing receptor (CaSR) signaling in the apical mem-
brane of the collecting duct functionally links renal Ca2 and
water metabolism (31). CaSR activation by high luminal Ca2
concentrations might result in a decrease in water permeability
of the collecting duct by downregulation of aquaporin-2 water
channels and consequently increase the urine volume (32,33).
We suggest that regulation of specific acid-base transport pro-
teins, possibly as a result of CaSR activation, is involved in the
observed urine acidification in TRPV5/ mice. The exact
mechanisms that are responsible for the urine acidification and
polyuria in TRPV5/ mice need further investigation.
The majority of the body Ca2 content is stored in bone,
where the balanced processes of bone formation and resorption
Figure 3. Renal calbindin-D28K and calbindin-D9K protein expression. Immunoblots of total kidney homogenates from TRPV5
/
and TRPV5/1-OHase/ mice probed with anti–calbindin-D28K (A) and anti–calbindin-D9K (B). Intensities of immunoposi-
tive bands were quantified by densitometry. Calbindin-D9K and calbindin-D28K expression levels were depicted relative to
TRPV5/ mice. Data are expressed as means  SEM. *P  0.05 significant difference from TRPV5/ mice.
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maintain bone homeostasis (34). Detailed microcomputed to-
mography and x-ray analyses showed bone abnormalities in all
three studied mouse models compared with wild-type mice.
TRPV5/ mice displayed reduced trabecular and cortical
bone thickness (14), which could be a consequence of the neg-
ative Ca2 balance as a result of the renal Ca2 leak. Moreover,
it was previously suggested that high serum 1,25(OH)2D3 levels
reduce cortical bone thickness, bone stiffness, and strength (35).
However, 1,25(OH)2D3 levels were not detectable in TRPV5
//
1-OHase/ mice, which demonstrated a significant decrease
in bone thickness, reduced bone mineralization, and rickets,
noticeably more severe than the bone abnormalities observed in
TRPV5/ and 1-OHase/mice (14,15). This suggested that
TRPV5 gene ablation might, at least in part, be directly respon-
sible for the detected bone abnormalities, independent of the
elevated serum 1,25(OH)2D3 levels. It is interesting that the
expression of TRPV5 and TRPV6 in bone tissue was previously
described and these epithelial Ca2 channels therefore could
serve as direct Ca2 providers in bone (20). However, this
hypothesis is hampered by the absence of comprehensive data
on the exact actions of these Ca2 channels in bone. Alterna-
tively, the aggravated bone phenotype demonstrated in
TRPV5//1-OHase/ mice could be explained by the sec-
ondary hyperparathyroidism leading to renal osteodystrophy.
Zheng et al. (36) recently studied the vitamin D receptor
(VDR)/calbindin-D28K double knockout mouse compared
with VDR or calbindin-D28K single gene–ablated mice. It is
interesting that the VDR/calbindin-D28K double knockout
mice displayed downregulation of intestinal and renal Ca2
transport proteins and a more aggravated phenotype, in-
cluding hypercalciuria and hyperparathyroidism, a further
decrease in bone mineral density and bone length, increased
distortion of the growth plate, a decrease in body weight,
and a decreased lifespan compared with the single gene–
ablated mice. In line with our results, this study clearly
revealed the critical role of vitamin D and Ca2 transport
proteins in Ca2 homeostasis and, moreover, the crucial
regulatory function of 1,25(OH)2D3 in the expression of in-
testinal and renal Ca2 transport protein.
On the basis of the present data, we ascertained the impor-
tant function of the renal Ca2 transport protein TRPV5 in Ca2
reabsorption and its possible involvement in bone Ca2 trans-
port, concomitant with a crucial role of 1,25(OH)2D3 in active
Ca2 (re)absorption by regulating epithelial Ca2 transport and
Ca2 transport protein expression. The observed polyuria and
urine acidification in TRPV5 knockout mice will need further
investigation to obtain more insight into the responsible mech-
anisms.
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Figure 4. Duodenal mRNA expression of Ca2 transport pro-
teins. Duodenal mRNA expression levels of TRPV6 (A), calbi-
ndin-D9K (B), and PMCA1b (C) in wild-type, 1-OHase
/,
TRPV5/, and TRPV5/1-OHase/ mice, assessed by re-
al-time PCR analysis and depicted as the ratio to HPRT mRNA
levels. Expression levels are presented relative to wild-type
mice. Data are expressed as means  SEM. *P  0.05 versus
wild-type mice; #P 0.05 significant difference from all groups.
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